Takeda Pharmaceutical Co Ltd (TKPHF) shareholders
TKPHFOTCPharmaceutical PreparationsAlso trades as TAK
$39.00+0.36 (+0.93%)
Close on Oct 19, 2026Market cap $134.41BP/E –Yield –
Ownership
Who owns Takeda Pharmaceutical's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 20 sales
Net sold $13.09M
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 121,185,145 | 7.70% | 13G (passive) amendment | Dec 31, 2023 |
| Sumitomo Mitsui Trust Holdings, Inc. | 87,400,834 | 5.50% | 13G (passive) amendment | Dec 31, 2023 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Andrew Stewart Plump | President, R&D, Director | 912,034 | Sep 3, 2026 |
| Julie So-Young Kim | President and CEO, Director | 391,489 | Aug 12, 2026 |
| Milano Furuta | Chief Financial Officer, Director | 70,200 | Jul 6, 2026 |
| Christophe Pierre Weber | President and CEO, Director | 418,803 | Apr 28, 2026 |
| Lauren Rusckowski Duprey | Chief Transformation Officer | 191,522 | Sep 15, 2026 |
| Nicola Deidre Petal Greenway | Chief Human Resources Officer | 40,049 | Aug 19, 2026 |
| Rhonda Janice Pacheco | President, U.S. Business Unit | 182,507 | Aug 12, 2026 |
| Awny Samaan Botros Farajallah | Chief Medical Officer | 116,177 | Aug 12, 2026 |
| Teresa Marie Bitetti | President, OBU | 252,010 | Aug 12, 2026 |
| Gabriele Ricci | Chief Data & Tech. Officer | 171,654 | Aug 12, 2026 |
| Ramy Riad Ahmed Ibrahim | President, PDT BU | 102,588 | Aug 12, 2026 |
| Elaine Mary Shannon | Pres., Global Supply & Quality | 67,311 | Aug 12, 2026 |
| Giles Richard Platford | President, IBU | 315,838 | Aug 12, 2026 |
| Agosti Marcello Pignagnoli | Head, Strat. & Port. Dev | 176,977 | Aug 12, 2026 |
| Natalie Anne Marie Furney | Global General Counsel | 204,298 | Aug 12, 2026 |
| Asuka Miyabashira | President, Japan Pharma B.U. | 4,500 | Jul 6, 2026 |
| Jennifer Marie Smoter | Chief Comm. & Gov. Officer | 18,808 | Jul 6, 2026 |
| Koichiro Kimura | Director | 1,800 | Jul 6, 2026 |
| Bruce D. Broussard | Director | 795 | Jul 6, 2026 |
| John Maraganore | Director | 10,400 | Jul 6, 2026 |
| Miki Tsusaka | Director | 8,200 | Jul 6, 2026 |
| Kimberly A. Reed | Director | 10,400 | Jul 6, 2026 |
| Masami Iijima | Director | 14,601 | Jul 6, 2026 |
| Paulus Stoffels | Director | 3,800 | Jul 6, 2026 |
| Steven Gillis | Director | 10,400 | Jul 6, 2026 |
| Yoshiaki Fujimori | Director | 27,865 | Mar 18, 2026 |
| Emiko Higashi | Director | 17,800 | Mar 18, 2026 |
| Jean Luc Butel | Director | 9,700 | Mar 18, 2026 |
| Ian T. Clark | Director | 9,700 | Mar 18, 2026 |
| Michel Bruno Orsinger | Director | 7,600 | Mar 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Lauren Rusckowski Duprey Chief Transformation Officer | Sep 14, 2026 | Sale | −34,535 | $18.54 | $640.28K | 191,522 |
| Andrew Stewart Plump President, R&D, Director | Sep 2, 2026 | Sale(10b5-1 plan) | −116,191 | $18.49 | $2.15M | 145,465 |
| Andrew Stewart Plump President, R&D, Director | Aug 19, 2026 | Sale(10b5-1 plan) | −19,651 | $18.49 | $363.35K | 261,656 |
| Nicola Deidre Petal Greenway Chief Human Resources Officer | Aug 18, 2026 | Sale | −12,980 | $18.11 | $235.07K | 40,049 |
| Elaine Mary Shannon Pres., Global Supply & Quality | Aug 11, 2026 | Sale | −20,363 | $17.55 | $357.37K | 67,311 |
| Teresa Marie Bitetti President, OBU | Aug 10, 2026 | Sale | −50,012 | $17.10 | $855.21K | 252,010 |
| Andrew Stewart Plump President, R&D, Director | Aug 10, 2026 | Sale | −165,393 | $17.10 | $2.83M | 766,569 |
| Awny Samaan Botros Farajallah Chief Medical Officer | Aug 10, 2026 | Sale | −14,006 | $17.10 | $239.50K | 116,177 |
| Nicola Deidre Petal Greenway Chief Human Resources Officer | Aug 10, 2026 | Sale | −6,774 | $17.10 | $115.84K | 53,029 |
| Nicola Deidre Petal Greenway Chief Human Resources Officer | Aug 10, 2026 | Sale | −975 | $17.50 | $17.06K | 93,431 |
| Nicola Deidre Petal Greenway Chief Human Resources Officer | Aug 10, 2026 | Sale | −33,628 | $17.51 | $588.83K | 59,803 |
| Rhonda Janice Pacheco President, U.S. Business Unit | Aug 10, 2026 | Sale | −16,901 | $17.10 | $289.01K | 182,507 |
| Natalie Anne Marie Furney Global General Counsel | Aug 10, 2026 | Sale | −30,868 | $17.10 | $527.84K | 204,298 |
| Agosti Marcello Pignagnoli Head, Strat. & Port. Dev | Aug 10, 2026 | Sale | −22,957 | $17.10 | $392.56K | 176,977 |
| Gabriele Ricci Chief Data & Tech. Officer | Aug 10, 2026 | Sale | −25,088 | $17.10 | $429.00K | 171,654 |
| Giles Richard Platford President, IBU | Aug 10, 2026 | Sale | −31,083 | $17.10 | $531.52K | 315,838 |
| Lauren Rusckowski Duprey Chief Transformation Officer | Aug 10, 2026 | Sale | −47,586 | $17.10 | $813.72K | 226,057 |
| Elaine Mary Shannon Pres., Global Supply & Quality | Aug 10, 2026 | Sale | −3,978 | $17.10 | $68.02K | 63,333 |
| Ramy Riad Ahmed Ibrahim President, PDT BU | Aug 10, 2026 | Sale | −7,277 | $17.10 | $124.44K | 102,588 |
| Julie So-Young Kim President and CEO, Director | Aug 10, 2026 | Sale | −89,090 | $17.10 | $1.52M | 391,489 |
| Steven Gillis Director | Jul 1, 2026 | Award | +3,800 | – | – | 10,400 |
| Natalie Anne Marie Furney Global General Counsel | Jul 1, 2026 | Award | +43,886 | – | – | 235,166 |
| Milano Furuta Chief Financial Officer, Director | Jul 1, 2026 | Award | +12,300 | – | – | 70,200 |
| Agosti Marcello Pignagnoli Head, Strat. & Port. Dev. | Jul 1, 2026 | Award | +27,586 | – | – | 199,934 |
| Paulus Stoffels Director | Jul 1, 2026 | Award | +3,800 | – | – | 3,800 |
| Lauren Rusckowski Duprey Chief Transformation Officer | Jul 1, 2026 | Award | +45,140 | – | – | 273,643 |
| Masami Iijima Director | Jul 1, 2026 | Award | +1,800 | – | – | 14,601 |
| Kimberly A. Reed Director | Jul 1, 2026 | Award | +3,800 | – | – | 10,400 |
| Koichiro Kimura Director | Jul 1, 2026 | Award | +1,800 | – | – | 1,800 |
| Andrew Stewart Plump President, R&D, Director | Jul 1, 2026 | Award | +125,390 | – | – | 931,962 |
| Teresa Marie Bitetti President, OBU | Jul 1, 2026 | Award | +43,886 | – | – | 302,022 |
| Nicola Deidre Petal Greenway Chief Human Resources Officer | Jul 1, 2026 | Award | +22,570 | – | – | 94,406 |
| Awny Samaan Botros Farajallah Chief Medical Officer | Jul 1, 2026 | Award | +17,554 | – | – | 130,183 |
| Jennifer Marie Smoter Chief Comm. & Gov. Officer | Jul 1, 2026 | Award | +18,808 | – | – | 18,808 |
| Giles Richard Platford President, IBU | Jul 1, 2026 | Award | +49,558 | – | – | 346,921 |
| Elaine Mary Shannon Pres., Global Supply & Quality | Jul 1, 2026 | Award | +30,094 | – | – | 87,674 |
| Asuka Miyabashira President, Japan Pharma B.U. | Jul 1, 2026 | Award | +1,500 | – | – | 4,500 |
| Miki Tsusaka Director | Jul 1, 2026 | Award | +1,800 | – | – | 8,200 |
| Ramy Riad Ahmed Ibrahim President, PDT BU | Jul 1, 2026 | Award | +25,078 | – | – | 109,865 |
| Rhonda Janice Pacheco President, U.S. Business Unit | Jul 1, 2026 | Award | +50,156 | – | – | 199,408 |
| John Maraganore Director | Jul 1, 2026 | Award | +3,800 | – | – | 10,400 |
| Bruce D. Broussard Director | Jul 1, 2026 | Award | +3,800 | – | – | 4,595 |
| Gabriele Ricci Chief Data & Tech. Officer | Jul 1, 2026 | Award | +37,616 | – | – | 196,742 |
| Julie So-Young Kim President and CEO, Director | Jul 1, 2026 | Award | +50,434 | – | – | 480,579 |
| Julie So-Young Kim President and CEO, Director | Jul 1, 2026 | Award | +22,800 | – | – | 22,800 |
| Christophe Pierre Weber President and CEO, Director | Apr 27, 2026 | Award | +165,370 | – | – | 418,803 |
| Christophe Pierre Weber President and CEO, Director | Apr 27, 2026 | Award | +78,900 | – | – | 1,014,200 |
| Andrew Stewart Plump President, R&D, Director | Apr 27, 2026 | Award | +212,470 | – | – | 806,572 |
| Giles Richard Platford President, IBU | Apr 27, 2026 | Award | +72,124 | – | – | 297,363 |
| Gabriele Ricci Chief Data & Tech. Officer | Apr 27, 2026 | Award | +34,994 | – | – | 159,126 |
| Agosti Marcello Pignagnoli Head, Strat. & Port. Dev. | Apr 27, 2026 | Award | +27,740 | – | – | 172,348 |
| Lauren Rusckowski Duprey Chief Transformation Officer | Apr 27, 2026 | Award | +59,990 | – | – | 228,503 |
| Julie So-Young Kim CEO - Elect | Apr 27, 2026 | Award | +105,416 | – | – | 430,145 |
| Milano Furuta Chief Financial Officer, Director | Apr 27, 2026 | Award | +7,800 | – | – | 57,900 |
| Teresa Marie Bitetti President, OBU | Apr 27, 2026 | Award | +64,988 | – | – | 258,136 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 15, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
3M shares short
Days to cover
716.8
At 0M shares a day
Change since last report
-2.9%
From 3M shares
Short volume, 0 days
–
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Takeda Pharmaceutical's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Lauren Rusckowski Duprey Chief Transformation Officer | Sep 10, 2026 | 34,535 | $634.41K | Sep 10, 2026 | Restricted Stock Unit Awards - Vested |
| Andrew Stewart Plump Officer | Sep 2, 2026 | 116,191 | $2.15M | Sep 2, 2026 | RSU's and PSU's |
| Andrew Stewart Plump Officer | Aug 19, 2026 | 19,651 | $363.35K | Aug 19, 2026 | RSU's and PSU's |
| Nicola Greenway Chief Human Resources Officer | Aug 14, 2026 | 12,980 | $225.72K | Aug 14, 2026 | Restricted Stock Unit Awards - Vested |
| Elaine Mary Shannon President, Global Supply & Quality | Aug 10, 2026 | 20,363 | $355.33K | Aug 11, 2026 | Restricted Stock Unit Awards - Vested |
| Nicola Greenway Chief Human Resources Officer | Aug 6, 2026 | 34,603 | $578.56K | Aug 7, 2026 | Restricted Stock Unit Awards - Vested |
| Andrew Stewart Plump President, Research & Development | Jul 13, 2026 | 179,239 | $3.00M | Jul 13, 2026 | Restricted Stock Unit Awards - Vested. |
| Rhonda Janice Pacheco President, US Business Unit and US Country Head | Jul 13, 2026 | 18,316 | $306.79K | Jul 13, 2026 | Restricted Stock Unit Awards - Vested. |
| Awny Farajallah Chief Medical Officer | Jul 13, 2026 | 15,188 | $254.40K | Jul 13, 2026 | Restricted Stock Unit Awards - Vested. |
| Ramy Riad President, Plasma-Derived Therapies Business Unit | Jul 13, 2026 | 7,889 | $132.15K | Jul 13, 2026 | Restricted Stock Unit Awards - Vested. |
| Elaine Mary Shannon President, Global Supply & Quality | Jul 13, 2026 | 4,319 | $72.35K | Jul 13, 2026 | Restricted Stock Unit Awards - Vested. |
| Nicola Greenway Chief Human Resources Officer | Jul 13, 2026 | 7,348 | $123.07K | Jul 13, 2026 | Restricted Stock Unit Awards - Vested. |
| Gabriele Ricci Chief Data & Technology Officer | Jul 13, 2026 | 27,197 | $455.54K | Jul 13, 2026 | Restricted Stock Unit Awards - Vested. |
| Natalie Furney Global General Counsel | Jul 13, 2026 | 33,454 | $560.35K | Jul 13, 2026 | Restricted Stock Unit Awards - Vested. |
| Giles Richard Platford President, International Business Unit | Jul 13, 2026 | 33,696 | $564.41K | Jul 13, 2026 | Restricted Stock Unit Awards - Vested. |